All Stories

  1. Extended follow-up of recurrent glioblastoma patients treated with boron neutron capture therapy (BNCT): Long-term survival from a Phase II trial (JG002) using Cyclotron Neutron Source and Boronophenylalanine
  2. Real-Time Augmented Reality Trajectory Lines Technique for Deep-Seated Glioblastoma: Technical Note
  3. Posterolateral Sulcus Approach for Intramedullary Hemorrhage Associated With Cavernous Malformation of High Cervical Spine: Operative Technique and Outcomes
  4. Development of a Theranostic Agent for Bone Metastases: Integration of Nuclear Medicine Imaging and Boron Neutron Capture Therapy (BNCT)
  5. Intelligent Ultrasonic Aspirator Controlled by Fiber-Optic Neoplasm Sensor Detecting 5-Aminolevulinic Acid-Derived Porphyrin Fluorescence
  6. C5 palsy following one- or two-level anterior cervical discectomy and fusion: Incidence and neurological recovery in a retrospective neurosurgical multicenter study
  7. Venous compression causes chronic cerebral ischaemia in normal pressure hydrocephalus patients
  8. Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT
  9. Abstracts of the 4th International Electronic Conference on Cancers (IECC2024): Insights into Cancer Metastasis, Biomarkers, Microenvironment, Immunotherapy, Pathophysiology, and Prevention
  10. Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors
  11. Postoperative Airway Management after Anterior Cervical Spine Surgery: Retrospective Neurosurgical Multicenter Study
  12. Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier
  13. Translational research of boron neutron capture therapy for spinal cord gliomas using rat model
  14. Chordoma Treatment with Boron Neutron Capture Therapy (BNCT): Experimental Insights
  15. Exploring BNCT as a Novel Approach for Metastatic Spinal Tumor Management
  16. Comparison of outcomes with/without preoperative embolization for meningiomas with diluted N-butyl-2-cyanoacrylate
  17. Exploring boron neutron capture therapy as a promising treatment for spinal cord gliomas: in vivo efficacy in rat models
  18. Treatment of High-grade Meningiomas
  19. Occult Germinoma of the Intramedullary Spinal Cord: A Case Report
  20. Expression and distribution of hypoxia‐inducible factor‐1α and vascular endothelial growth factor in comparison between radiation necrosis and tumor tissue in metastatic brain tumor: A case report
  21. Actin Alpha 2, Smooth Muscle (ACTA2) Is Involved in the Migratory Potential of Malignant Gliomas, and Its Increased Expression at Recurrence Is a Significant Adverse Prognostic Factor
  22. Increasing C-reactive protein levels in a patient with glioblastoma with lymph node metastasis: a case report
  23. Development of a prompt gamma-ray detector with an 8 × 8 array LaBr 3(Ce) scintillator and a multi-pixel photon counter for boron neutron capture therapy
  24. Surgical Outcomes and Medical Costs Associated with Spinal Cord Tumors: Comparison of Extramedullary and Intramedullary Tumors
  25. Correction to: Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy
  26. Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy
  27. Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated closo-Dodecaborate on a Rat Brain Tumor Model
  28. Occult neurohypophyseal germinoma discovered during the course of long-term diabetes insipidus: illustrative case
  29. Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated Closo-Dodecaborate on a Rat Brain Tumor Model
  30. Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP)
  31. Is Intraoperative 5-ALA PDD Effective for Brain Tumors Other than Malignant Gliomas!?—5-ALA PDD and Preoperative Image Analysis in Metastatic Brain Tumors—
  32. 「脳神経外科領域におけるPDD」の特集によせて
  33. 脳神経外科における鏡視下5-ALA蛍光ガイド下手術の変遷と新たな問題点
  34. 5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
  35. Increasing C-reactive protein levels in a patient with glioblastoma with lymph node metastasis. A case report
  36. Using virtual lines of navigation for a successful transcortical approach
  37. Boron uptake of boronophenylalanine and the effect of boron neutron capture therapy in cervical cancer cells
  38. Chronic expanding pituitary hematoma with calcification resulting from pituitary adenoma: illustrative case
  39. Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells
  40. Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model
  41. Influence of surgical position and registration methods on clinical accuracy of navigation systems in brain tumor surgery
  42. Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model
  43. The safety of spine surgery in the late-stage elderly of 75 years of age or older: A retrospective multicenter study
  44. Treatment Outcomes of 94 Cases of Pipeline Embolization Device in a Single Center: Predictive Factors of Incomplete Aneurysm Occlusion
  45. Usefulness of Step-by-Step Anterior Clinoidectomy for Neck Clipping of Paraclinoid Aneurysms
  46. Vertebral artery is an anatomical landmark in the posterior unilateral resection of cervical benign nerve sheath tumors with dumbbell extension of Eden type 2 or 3
  47. Characteristic and Management of Symptomatic Septum Pellucidum Cyst in Extreme Elderly Patient: Case Report and Literature Review
  48. PEDT-10 PHASE II TRIAL OF PATHOLOGY-BASED THREE-GROUP TREATMENT STRATIFICATION FOR PATIENTS WITH CNS GERM CELL TUMORS: A LONG-TERM FOLLOW-UP STUDY
  49. The effect of hypoxia on photodynamic therapy with 5-aminolevulinic acid in malignant gliomas
  50. RT-6 POTENTIAL AND PROSPECTS OF BORON NEUTRON CAPTURE THERAPY USING A COMBINATION OF MULTIPLE BORON AGENTS
  51. Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan
  52. RTID-06. A RANDOMIZED CONTROLLED TRIAL USING ACCELERATOR-BASED BNCT SYSTEM FOR REFRACTORY RECURRENT HIGH-GRADE MENINGIOMA
  53. Boron Compounds for Neutron Capture Therapy in the Treatment of Brain Tumors
  54. Proceedings to the 59th Annual Conference of the Particle Therapy Cooperative Group (PTCOG59 2021 Online)
  55. Anti-tumor effect of boron neutron capture therapy in pelvic human colorectal cancer in a mouse model
  56. Multimodal Management of Combined Posterior and Anterior Surgical Approach and Postoperative Pharmacological Therapy for Giant Cell Tumor of the Cervical Spine Encasing the Vertebral Artery: A Technical Case Report
  57. The Characteristic of Light Sources and Fluorescence in 3-Dimensional Digital Exoscope “ORBEYE” for 5-Aminolevulinic Acid Induced Fluorescence Guided Surgery Compare with Conventional Microscope
  58. Endoscopic Transnasal Resection for Chordoma Invaded to Lower-Third Clivus—Usefulness of Preoperative Simulation With Virtual Endoscopic Imaging: 2-Dimensional Operative Video
  59. Anatomical Limitation of Posterior Spinal Myelotomy for Intramedullary Hemorrhage Associated with Ependymoma or Cavernous Malformation of the High Cervical Spine
  60. Corrigendum: Evaluation of the Effectiveness of the Tap Test by Combining the Use of Functional Gait Assessment and Global Rating of Change
  61. Bilateral Posterolateral Sulcus Approach for the Removal of Spinal Intramedullary Metastatic Adenocarcinoma: A Technical Case Report
  62. Frameless Stereotactic Biopsy with Intraoperative Computed Tomography "Assessment of Efficacy and Real Target Registration Error"
  63. Evaluation of the Effectiveness of the Tap Test by Combining the Use of Functional Gait Assessment and Global Rating of Change
  64. Boron neutron capture therapy and add-on bevacizumab in patients with recurrent malignant glioma
  65. Surgical strategy for tuberculous brain abscess with dural infiltration: A case report
  66. Treatment and Pathophysiology of Clinoidal Meningiomas
  67. Near-infrared immunotherapy targeting both EGFR and IL13Rα2 antigens for glioblastoma
  68. Usefulness of intraoperative PDD under 5-ALA administration in brain tumors
  69. The Effect of Hypoxia on Photodynamic Therapy with 5-Aminolevulinic Acid in Malignant Gliomas
  70. Development of an irradiation method for superficial tumours using a hydrogel bolus in an accelerator-based BNCT
  71. Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation
  72. Dodecaborate Conjugates Targeting Tumor Cell Overexpressing Translocator Protein for Boron Neutron Capture Therapy
  73. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model
  74. Chronic pathophysiological changes in the normal brain parenchyma caused by radiotherapy accelerate glioma progression
  75. RTID-07. AN INVESTIGATOR-LEAD PHASE II CLINICAL TRIAL OF ACCELERATOR-BASED BNCT FOR REFRACTORY AND RECURRENT HIGH-GRADE MENINGIOMA
  76. Translational Evaluation of a Dodecaborated Albumin Conjugate With Maleimide as a Boron Delivery System for a Neutron Capture Reaction to an F98 Rat Glioma Model
  77. Development of novel Mixed Reality-Based Simulator for Endoscopic Transnasal Surgery with HoloLens and multiple AR tracker
  78. Boron Neutron Capture Therapy and Add-on Bevacizumab in Patients with Recurrent Malignant Glioma
  79. Establishment of multi-target neutron capture therapy with multiple boron drugs for brain tumours
  80. Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study
  81. Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
  82. The Up-Regulation of CXCL12-CXCR4 Axis By Radiotherapy Could Accelerate Glioma Progression
  83. Abstracts of the 79th Annual Meeting of the Japanese Cancer Association; 2020 Oct 1‐3; Hiroshima, Japan as Cancer Science, Supplement 1, Vol 112 (2021)
  84. Long-Term Prognosis of Cognitive Function in Patients With Idiopathic Normal Pressure Hydrocephalus After Shunt Surgery
  85. Pituitary stone resulting in visual dysfunction and spontaneous rhinorrhea in nonfunctioning pituitary adenoma: illustrative case
  86. The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
  87. Characteristic evaluation of the thermal neutron irradiation field using a 30 MeV cyclotron accelerator for basic research on neutron capture therapy
  88. Optic Nerve Root Enhancement in Gadolinium-Enhanced Magnetic Resonance Imaging of Rathke’s Cleft Cyst: a Case Report
  89. CTNI-56. A PHASE II CLINICAL TRIAL USING ACCELERATOR-BASED BNCT SYSTEM FOR REFRACTORY RECURRENT HIGH-GRADE MENINGIOMA
  90. NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET
  91. STMO-07 Adverse events related to the glioblastoma surgery and their perioperative management in our hospital
  92. Evaluation of the energy resolution of a prompt gamma-ray imaging detector using LaBr3(Ce) scintillator and 8 × 8 array MPPC for an animal study of BNCT
  93. Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
  94. Newly Developed Aneurysm at the Anastomosis Site of a Superficial Temporal Artery to Middle Cerebral Artery Bypass Successfully Treated by Endovascular Embolization
  95. A case of congenital afibrinogenemia with intracranial hemorrhage
  96. Other Hospital-onset Acute Ischemic Stroke Due to Large Vessel Occlusion Treated by Mechanical Thrombectomy after Inter-hospital Transfer
  97. ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
  98. RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
  99. TB-03 THE SURVIVAL PROLONGATION EFFECT OF NOVEL BORON COMPOUND FOR BNCT USING RAT BRAIN TUMOR MODEL
  100. Refractory chronic subdural hematoma associated with dural metastasis of lung adenocarcinoma treated with endovascular embolization for the middle meningeal artery: a case report
  101. Development of a real-time neutron detector for measurement at whole body position in BNCT
  102. The Efficacy of Pure Navigation-System Guided Biopsy With 5-ALA Induced Photodynamic Diagnosis for Malignant Brain Tumors
  103. Development of proton beam irradiation system for small animals using FFAG accelerator
  104. Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review
  105. Characteristics and Treatment Results of In-hospital Acute Ischemic Stroke due to Large Vessel Occlusion Treated by Mechanical Thrombectomy
  106. Stent-assisted Coil Embolization Using a Low-profile Visualized Intraluminal Support Device: Characteristics and Outcomes of the Braided Stent
  107. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents
  108. Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats
  109. RTHP-38. BNCT COMBINED WITH EARLY SUCCESSIVE BEVACIZUMAB TREATMENTS FOR RECURRENT MALIGNANT GLIOMAS
  110. RTHP-39. SINGLE ARM, MULTI-CENTRIC PHASE II CLINICAL STUDY NAMED “BORON NEUTRON CAPTURE THERAPY AND TEMOZOLOMIDE IN TREATING PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME”
  111. Fluoroscopic-Guided Paramedian Approach for Lumbar Catheter Placement in Cerebrospinal Fluid Shunting: Assessment of Safety and Accuracy
  112. Boron Neutron Capture Therapy for High-Grade Skull-Base Meningioma
  113. Continuous Blood Glucose Monitoring May Detect Carotid Occlusion Intolerance during Carotid Artery Stenting
  114. Spectral Radiance of Protoporphyrin IX Fluorescence and Its Histopathological Implications in 5-Aminolevulinic Acid-Guided Surgery for Glioblastoma
  115. Assessment of safety of 5-aminolevulinic acid–mediated photodynamic therapy in rat brain
  116. Boron Neutron Capture Therapy of Malignant Gliomas
  117. Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
  118. Neurosurgical microscopic solid laser-based light inhibits photobleaching during fluorescence-guided brain tumor removal with 5-aminolevulinic acid
  119. Limit of intraoperative near-infrared spectroscopy monitoring during endovascular thrombectomy in acute ischemic stroke
  120. ACTR-09. BORON NEUTRON CAPTURE THERAPY WITH THE COMBINATION OF SUCCESSIVE BEVACIZUMAB TREATMENTS FOR RECURRENT MALIGNANT GLIOMAS
  121. ACTR-70. IMPACT OF BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA AND POOR PERFORMANCE STATUS
  122. Differential diagnosis using fluoride-labeled boronophenylalanine (FBPA) PET for post-therapeutic change from recurrence on the patients with malignant glioma
  123. Reactor-based Boron Neutron Capture Therapy (BNCT) for the patients with recurrent malignant glioma
  124. Intraoperative 5-aminolevulinic acid-induced photodynamic diagnosis of metastatic brain tumors with histopathological analysis
  125. Transthyretin Concentrations in Acute Stroke Patients Predict Convalescent Rehabilitation
  126. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma
  127. Note: Development of real-time epithermal neutron detector for boron neutron capture therapy
  128. P17.10 BNCT for the treatment of malignant brain tumors, from reactor to accelerator
  129. Age-related variations in global spinal alignment and sagittal balance in asymptomatic Japanese adults
  130. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
  131. RTHP-03. GENE EXPRESSION LANDSCAPE INCLUDING miRNAs IN DELAYED RADIATION NECROSIS OF BRAIN
  132. OS3.5 Gene expression landscape including miRNAs of delayed radiation necrosis in brain
  133. Successful recanalization for internal carotid artery occlusion with persistent primitive trigeminal artery manifesting only as ischemia of the posterior circulation
  134. Boron Neutron Capture Therapy for Malignant Brain Tumors
  135. Usefulness of Three-dimensional Stereoscopic Images for Cerebral Endovascular Treatment
  136. Spinopelvic alignment and sagittal balance of asymptomatic adults with 6 lumbar vertebrae
  137. Delayed brain radiation necrosis: pathological review and new molecular targets for treatment
  138. The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model
  139. Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas
  140. Tetrakis( p -Carboranylthio-Tetrafluorophenyl)Chlorin (TPFC): Application for Photodynamic Therapy and Boron Neutron Capture Therapy
  141. Brain Tumor
  142. Comparison of vertebroplasty versus vertebral perforation for the treatment of acute vertebral compression fractures
  143. Intravenous Administration of Bevacizumab for the Treatment of Symptomatic Radiation Necrosis in the Brain with the Diagnosis based on Amino Acid PET—Advanced Therapy of Type B for NDA Approval—
  144. Pathophysiology, Diagnosis, and Treatment of Radiation Necrosis in the Brain
  145. Foramen magnum dural arteriovenous fistula treated by a microsurgical technique combined with a feeder occlusion using the transarterial coil embolization
  146. Transvenous Embolization for an Isolated Galenic Dural Arteriovenous Fistula Associated with Marfan Syndrome: A Case Report
  147. Clinical Significance of Postoperative Changes in Redundant Nerve Roots After Decompressive Laminectomy for Lumbar Spinal Canal Stenosis
  148. Postoperative change in sagittal balance after Kyphoplasty for the treatment of osteoporotic vertebral compression fracture
  149. A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
  150. Effect of boron neutron capture therapy for recurrent anaplastic meningioma: an autopsy case report
  151. Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis
  152. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide
  153. Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
  154. The roles of platelet-derived growth factors and their receptors in brain radiation necrosis
  155. Boron neutron capture therapy for recurrent high-grade meningiomas
  156. Experimental Study to Understand Nonspecific Protoporphyrin IX Fluorescence in Brain Tissues Near Tumors After 5-Aminolevulinic Acid Administration
  157. High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation
  158. A Patient With Glioblastoma Who Died From Lung and Pleural Lesions With Rapid Progression
  159. Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases
  160. Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model
  161. Bevacizumab Treatment for Symptomatic Radiation Necrosis Diagnosed by Amino Acid PET
  162. Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
  163. 3P033 Design of Photo-controllable Cyclic Peptides(01A. Protein: Structure,Poster)
  164. Abstract 738: Re-irradiation for recurrent malignant glioma by boron neutron capture therapy
  165. Intraoperative ICG Angiography
  166. Boron Neutron Capture Therapy for Malignant Meningiomas
  167. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
  168. Boron neutron capture therapy for clear cell sarcoma (CCS): Biodistribution study of p-borono-l-phenylalanine in CCS-bearing animal models
  169. Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme—Study design and current status report
  170. Clinical Study on Modified Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma
  171. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles
  172. Computed Tomography Imaging of Transferrin Targeting Liposomes Encapsulating Both Boron and Iodine Contrast Agents by Convection-Enhanced Delivery to F98 Rat Glioma for Boron Neutron Capture Therapy
  173. Fluorine-18-labeled boronophenylalanine positron emission tomography for oral cancers: Qualitative and quantitative analyses of malignant tumors and normal structures in oral and maxillofacial regions
  174. Application of a novel boronated porphyrin (H2OCP) as a dual sensitizer for both PDT and BNCT
  175. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors
  176. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases
  177. Usefulness of the novel boronated porphyrins administerd by convection enhanced delivery for photodynamic therapy
  178. A case of unruptured peripheral middle cerebral artery aneurysm associated with Churg-Strauss syndrome
  179. Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas
  180. Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node
  181. Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice
  182. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients
  183. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas
  184. Boron neutron capture therapy for papillary cystadenocarcinoma in the upper lip: A case report
  185. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: A case report
  186. Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma
  187. 303 A Sensory Feedback System for EMG-Controlled Prosthetic Hands
  188. Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas
  189. Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas
  190. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy
  191. BNCT Displays Growth-inhibitory Effect on Malignant Meningioma Cell In Vivo
  192. Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis
  193. 365 POSTER Origin of 5-ALA-induced PpIX at brain tissues surrounding tumor (in vitro photometrical study)
  194. 947 POSTER Target volume reduction in the treatment of malignant meningioma by boron neutron capture therapy
  195. BORON NEUTRON CAPTURE THERAPY FOR MALIGNANT TUMORS RELATED TO MENINGIOMAS
  196. Molecular Targeting and Treatment of an Epidermal Growth Factor Receptor-Positive Glioma Using Boronated Cetuximab
  197. Analysis of Boron DistributionIn Vivofor Boron Neutron Capture Therapy using Two Different Boron Compounds by Secondary Ion Mass Spectrometry
  198. Ruptured aneurysm at the cortical segment of the posterior inferior cerebellar artery
  199. Molecular Targeting and Treatment of EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibody L8A4
  200. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT
  201. Model analysis of coil embolization of cerebral aneurysms: prediction of thrombus formation in aneurysms based on the coil embolization rate
  202. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates
  203. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages
  204. Preferential Recurrence of a Sarcomatous Component of a Gliosarcoma after Boron Neutron Capture Therapy: Case Report
  205. Experience of modified boron neutron capture therapy to a glioblastoma patient
  206. The Early Successful Treatment of Glioblastoma Patients with Modified boron Neutron Capture Therapy
  207. Intra-operative measurement of cortical arterial flow volumes in posterior circulation using Doppler sonography
  208. Surgical Strategy for Meningioma Extension into the Optic Canal.
  209. Paraclinoid aneurysms of the internal carotid artery: Hydraulic simulation study on their locations and shape of the carotid siphon
  210. Simulation of therapeutic parent artery occlusion for basilar head aneurysms. Hemodynamic effect of occlusion sites and diameters of collateral arteries
  211. Efficacy of an Ultrasonic Aspirator for Compartmental Removal of Large Meningiomas.
  212. Surgical treatment of distal cervical internal carotid artery aneurysm
  213. Superficial temporal artery to posterior cerebral artery bypass using the posterior temporal artery as a recipient.
  214. A Pylorus-Retaining Pancreatic Head Duodenectomy for Cancers of the Duodenal Papilla and the Lower Bile Duct.
  215. Total Gastrectomy for Gastric Cancer: 12-Year Data and Review of the Effect of Performing Lymphadenectomy.